MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic- pathologic correlation

American Journal of Roentgenology

Volumn 172, Issue 5, 1999, Pages 1347-1351

  Harisinghani, Mukesh G ^a   Saini, Sanjay ^a   Weissleder, Ralph ^a   Hahn, Peter F ^a   Yantiss, Rhonda K ^a   Tempany, Clare ^b   Wood, Bradford J ^a   Mueller, P R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ABDOMINAL TUMOR; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; LYMPHANGIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS TUMOR; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0032758335     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.172.5.10227514     Document Type: Article

References (23)

1. De Meester T, Beckerman C, Joseph J, et al. Gallium 67 scanning for carcinoma of the lung. J Thoracic Cardiovasc Surg 1976;72:695-708
2. Berek J, Hacker N, Fu Y, et al. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastases and survival. Obstet Gynecol 1985;65:46-52
3. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175:494-498
4. McLachlan SJ, Morris M, Lucas MA, et al. Preliminary clinical experience with AMI 227. Acad Radiol 1996;3[suppl 2]:S295-S296
5. Bengele H, Palmacci S, Rogers J, et al. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. Magn Reson Imaging 1994;12:433-442
6. Harisinghani MG, Saini S, Slater GJ, et al. MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging 1997;7:161-163
7. Harisinghani MG, Saini S, Hahn PF, Weissleder R, Mueller PR. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex). Acad Radiol 1998; 5[suppl 1]:S167-S169
8. Guimaraes R, Clement O, Bittoun J, et al. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis of contrast enhancement. AJR 1994;162:201-207
9. Weissleder R, Elizondo G, Josephson L, et al. Experimental lymph node metastases: enhanced detection with MR lymphography. Radiology 1989; 171:835-839
10. Hamm B, Taupitz M, Hussmann P, et al. MR lymphography with iron oxide particles: dose response studies and pulse sequence optimization in rabbits. AJR 1992;158:183-190
11. Vassallo P, Matei C, Heston W, et al. AMI-227 enhanced lymphography: usefulness for differentiating reactive from tumor bearing lymph nodes. Radiology 1994;193:501-506
12. Anzai Y, Blackwell K, Hirschowitz S, et al. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994;192:709-715
13. McLachlan S, Morris M, Lucas M, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 1994;4:301-307
14. Bellin M, Roy C, Kinkel K, et al. Lymph node metastases: safety and effectiveness on MR imaging with ultrasmall superparamagnetic iron oxide particles - initial clinical experience. Radiology 1998;207:799-808
15. Castellino R, Hoppe R, Blank N, et al. Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin's disease. AJR 1984;143:37-41
16. Castellino R. Hodgkin disease: practical concepts for the diagnostic radiologist. Radiology 1986; 159:305-310
17. Dooms G, Hricak H. Radiologic imaging modalities, including magnetic resonance, for evaluating lymph nodes. West J Med 1986;144:49-57
18. Buckwalter K, Ellis J, Baker D, et al. Pitfalls in MR imaging of lymphadenopathy after lymphangiography. Radiology 1986;161:831-832
19. Dooms GC, Hricak H, Crooks LE, et al. Magnetic resonance imaging of the lymph nodes: comparison with CT. Radiology 1984;153:719-728
20. Lee JK, Heiken JP, Ling D, et al. Magnetic resonance imaging of abdominal and pelvic lymphadenopathy. Radiology 1984;153:181-188
21. Anzai Y, McLachlan S, Morris M, et al. Dextrancoated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. AJNR 1994;15:87-94
22. Anzai Y, Prince MR. Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer. J Magn Reson Imaging 1997;7:75-81
23. Anzai Y, Brunberg JA, Lufkin RB. Imaging of nodal metastases in the head and neck. J Magn Reson Imaging 1997;7:774-783